Mechanisms of androgenic action in adipose tissue

Future Lipidology

Volumn 4, Issue 3, 2009, Pages 367-378

  Veilleux, Alain ^a   Blouin, Karine ^a   Tchernof, André ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Adipogenesis; Adipose tissue; Aldo keto reductases 1C; Androgen; Androgen receptor; ARA70; Body fat distribution; Dihydrotestosterone; Glucocorticoid; Steroid converting enzyme; Testosterone; Wnt pathway

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ADIPOCYTOKINE; ANDROGEN; ANDROGEN RECEPTOR; ANDROGEN RECEPTOR ASSOCIATED 70 PROTEIN; ANDROSTANOLONE; BETA CATENIN; DEXAMETHASONE; HORMONE RECEPTOR AFFECTING AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRASTERONE; TESTOSTERONE; UNCLASSIFIED DRUG; WNT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANDROGEN METABOLISM; ANDROGEN SYNTHESIS; BODY FAT DISTRIBUTION; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG MECHANISM; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; LIPID METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TISSUE LEVEL; TISSUE METABOLISM; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS;

EID: 67249127385     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/CLP.09.16     Document Type: Review

References (94)

1. Despres JP, Lemieux I: Abdominal obesity and metabolic syndrome. Nature 444(7121), 881-887 (2006).
2. Blouin K, Boivin A, Tchernof A: Androgens and body fat distribution. J. Steroid Biochem. Mol. Biol. 108(3-5), 272-280 (2008).
3. Woodhouse LJ, Gupta N, Bhasin M et al.: Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J. Clin. Endocrinol. Metab. 89(2), 718-726 (2004).
4. Gruber DM, Sator MO, Kirchengast S, Joura EA, Huber JC: Effect of percutaneous androgen replacement therapy on body composition and body weight in postmenopausal women. Maturitas 29(3), 253-259 (1998).
5. Sato T, Matsumoto T, Yamada T et al.: Late onset of obesity in male androgen receptor-deficient (AR KO) mice. Biochem. Biophys. Res. Commun. 300(1), 167-171 (2003).
6. Fan W, Yanase T, Nomura M et al.: Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54(4), 1000-1008 (2005).
7. Bélanger C, Luu-The V, Dupont P, Tchernof A: Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity. Horm. Metab. Res. 34(11-12), 737-745 (2002).
8. Blouin K, Veilleux A, Luu-The V, Tchernof A: Androgen metabolism in adipose tissue: recent advances. Mol. Cell. Endocrinol. 301(1-2), 97-103 (2008).
9. Belanger C, Hould FS, Lebel S et al.: Omental and subcutaneous adipose tissue steroid levels in obese men. Steroids 71(8), 674-682 (2006).
10. Feher T, Halmy L, Bodrogi L, Kazik MH: Dehydroepiandrosterone concentration in adipose tissue of normal and overweight subjects. Horm. Metab. Res. 8(5), 372-374 (1976).
11. Borg W, Shackleton CH, Pahuja SL, Hochberg RB: Long-lived testosterone esters in the rat. Proc. Natl Acad. Sci. USA 92(5), 1545-1549 (1995).
12. Szymczak J, Milewicz A, Thijssen JH, Blankenstein MA, Daroszewski J: Concentration of sex steroids in adipose tissue after menopause. Steroids 63(5-6), 319-321 (1998).
13. Feher T, Bodrogi L: A comparative study of steroid concentrations in human adipose tissue and the peripheral circulation. Clin. Chim. Acta 126(2), 135-141 (1982).
14. Deslypere JP, Verdonck L, Vermeulen A: Fat tissue: a steroid reservoir and site of steroid metabolism. J. Clin. Endocrinol. Metab. 61(3), 564-570 (1985).
15. Cleland WH, Mendelson CR, Simpson ER: Aromatase activity of membrane fractions of human adipose tissue stromal cells and adipocytes. Endocrinology 113(6), 2155-2160 (1983).
16. Blouin K, Richard C, Brochu G et al.: Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. J. Endocrinol. 191(3), 637-649 (2006).
17. Blouin K, Richard C, Belanger C et al.: Local androgen inactivation in abdominal visceral adipose tissue. J. Clin. Endocrinol. Metab. 88(12), 5944-5950 (2003).
18. Miller LK, Kral JG, Strain GW, Zumoff B: Androgen binding to ammonium sulfate precipitates of human adipose tissue cytosols. Steroids 55(9), 410-415 (1990).
19. Pedersen SB, Fuglsig S, Sjogren P, Richelsen B: Identification of steroid receptors in human adipose tissue. Eur. J. Clin. Invest. 26(12), 1051-1056 (1996).
20. Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y: Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am. J. Physiol. 274(6 Pt 1), 1645-1652 (1998).
21. Joyner J, Hutley L, Cameron D: Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes. Horm. Metab. Res. 34(5), 223-228 (2002).
22. Rodriguez-Cuenca S, Monjo M, Proenza AM, Roca P: Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu. Am. J. Physiol. Endocrinol. Metab. 288(1), E200-E207 (2005).
23. Blouin K, Nadeau M, Mailloux J et al.: Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis. Am. J. Physiol. Endocrinol. Metab. 296(2), E244-E255 (2009).
24. Lacasa D, Agli B, Moynard D, Giudicelli Y: Evidence for a regional-specific control of rat preadipocyte proliferation and differentiation by the androgenic status. Endocrine 3, 789-793 (1995).
25. De Pergola G, Xu XF, Yang SM, Giorgino R, Bjorntorp P: Up-regulation of androgen receptor binding in male rat fat pad adipose precursor cells exposed to testosterone: study in a whole cell assay system. J. Steroid Biochem. Mol. Biol. 37(4), 553-558 (1990).
26. Chen F, Knecht K, Leu C et al.: Partial agonist/antagonist properties of androstenedione and 4-androsten-3β,17β-diol. J. Steroid Biochem. Mol. Biol. 91(4-5), 247-257 (2004).
27. 14C-dehydroepiandrosterone in female adipose tissue and venous blood. Endocrinol. Exp. 9(3), 215-222 (1975).
28. Losel RM, Falkenstein E, Feuring M et al.: Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83(3), 965-1016 (2003).
29. Heinlein CA, Chang C: Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 23(2), 175-200 (2002).
30. Yeh S, Chang C: Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl Acad. Sci. USA 93(11), 5517-5521 (1996).
31. Miyamoto H, Rahman M, Takatera H et al.: A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth. J. Biol. Chem. 277(7), 4609-4617 (2002).
32. Nishizuka M, Tsuchiya T, Nishihara T, Imagawa M: Induction of Bach1 and ARA70 gene expression at an early stage of adipocyte differentiation of mouse 3T3-L1 cells. Biochem. J. 361(Pt 3), 629-633 (2002).
33. Heinlein CA, Ting HJ, Yeh S, Chang C: Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor γ. J. Biol. Chem. 274(23), 16147-16152 (1999).
34. Zieleniak A, Wojcik M, Wozniak LA: Structure and physiological functions of the human peroxisome proliferator-activated receptor γ. Arch. Immunol. Ther. Exp. (Warsz.) 56(5), 331-345 (2008).
35. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC: Interaction of nuclear receptors with the Wnt/β-catenin/Tcf signaling axis: Wnt you like to know? Endocr. Rev. 26(7), 898-915 (2005).
36. Singh R, Artaza JN, Taylor WE et al.: Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with β-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147(1), 141-154 (2006).
37. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A: Adipogenesis and WNT signalling. Trends Endocrinol. Metab. 20(1), 16-24 (2008).
38. Schweizer L, Rizzo CA, Spires TE et al.: The androgen receptor can signal through Wnt/β-catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens. BMC Cell Biol. 9, 4 (2008).
39. 2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet. 16(7), 279-283 (2000).
40. Moldes M, Zuo Y, Morrison RF et al.: Peroxisome-proliferator-activated receptor γ suppresses Wnt/ β-catenin signalling during adipogenesis. Biochem. J. 376(Pt 3), 607-613 (2003).
41. Kennell JA, O'Leary EE, Gummow BM, Hammer GD, MacDougald OA: T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with β-catenin to coactivate C/EBPα and steroidogenic factor 1 transcription factors. Mol. Cell. Biol. 23(15), 5366-5375 (2003).
42. Bennett CN, Hodge CL, MacDougald OA, Schwartz J: Role of Wnt10b and C/ EBPα in spontaneous adipogenesis of 243 cells. Biochem. Biophys. Res. Commun. 302(1), 12-16 (2003).
43. Bennett CN, Ross SE, Longo KA et al.: Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277(34), 30998-31004 (2002).
44. Truica CI, Byers S, Gelmann EP: β-catenin affects androgen receptor transcriptional activity and ligand specificity. Cancer Res. 60(17), 4709-4713 (2000).
45. Yang F, Li X, Sharma M et al.: Linking β-catenin to androgen-signaling pathway. J. Biol. Chem. 277(13), 11336-11344 (2002).
46. Pawlowski JE, Ertel JR, Allen MP et al.: Liganded androgen receptor interaction with β-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. J. Biol. Chem. 277(23), 20702-20710 (2002).
47. Christodoulides C, Laudes M, Cawthorn WP et al.: The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J. Cell Sci. 119(Pt 12), 2613-2620 (2006).
48. Heinlein CA, Chang C: The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol. Endocrinol. 16(10), 2181-2187 (2002).
49. Gupta V, Bhasin S, Guo W et al.: Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes. Mol. Cell Endocrinol. 296(1-2), 32-40 (2008).
50. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S: Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/ 2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144(11), 5081-5088 (2003).
51. Bolduc C, Larose M, Yoshioka M et al.: Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. J. Mol. Endocrinol. 33(2), 429-444 (2004).
52. Bolduc C, Yoshioka M, St Amand J: Transcriptomic characterization of the long-term dihydrotestosterone effects in adipose tissue. Obesity (Silver Spring) 15(5), 1107-1132 (2007).
53. Zhang Y, Calvo E, Martel C, Luu-The V, Labrie F, Tchernof A: Response of the adipose tissue transcriptome to dihydrotestosterone in mice. Physiol. Genomics 35(3), 254-261 (2008).
54. Lacasa D, Garcia E, Henriot D, Agli B, Giudicelli Y: Site-related specificities of the control by androgenic status of adipogenesis and mitogen-activated protein kinase cascade/c-fos signaling pathways in rat preadipocytes. Endocrinology 138(8), 3181-3186 (1997).
55. Anderson LA, McTernan PG, Harte AL, Barnett AH, Kumar S: The regulation of HSL and LPL expression by DHT and flutamide in human subcutaneous adipose tissue. Diabetes Obes. Metab. 4(3), 209-213 (2002).
56. Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y: Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor γ2. Endocrinology 141(2), 649-656 (2000).
57. Monjo M, Pujol E, Roca P: α2- to β3-adrenoceptor switch in 3T3-L1 preadipocytes and adipocytes: modulation by testosterone, 17β-estradiol, and progesterone. Am. J. Physiol. Endocrinol. Metab. 289(1), E145-E150 (2005).
58. Blouin K, Nadeau M, Perreault M et al.: Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clin. Endocrinol. (In press) (2009).
59. McIntosh MK, Lea-Currie YR, Geigerman C, Patseavouras L: Dehydroepiandrosterone alters the growth of stromal vascular cells from human adipose tissue. Int. J. Obes. Relat. Metab. Disord. 23(6), 595-602 (1999).
60. Lea-Currie YR, Monroe D, McIntosh MK: Dehydroepiandrosterone and related steroids alter 3T3-L1 preadipocyte proliferation and differentiation. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol. 123(1), 17-25 (1999).
61. Elbers JM, de Jong S, Teerlink T et al.: Changes in fat cell size and in vitro lipolytic activity of abdominal and gluteal adipocytes after a one-year cross-sex hormone administration in transsexuals. Metabolism 48(11), 1371-1377 (1999).
62. Rebuffe-Scrive M, Marin P, Bjorntorp P: Effect of testosterone on abdominal adipose tissue in men. Int. J Obes. 15(11), 791-795 (1991).
63. Xu X, De Pergola G, Bjorntorp P: The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 126(2), 1229-1234 (1990).
64. Hansen FM, Fahmy N, Nielsen JH: The influence of sexual hormones on lipogenesis and lipolysis in rat fat cells. Acta Endocrinol. (Copenh.) 95(4), 566-570 (1980).
65. Pecquery R, Leneveu MC, Giudicelli Y: Influence of androgenic status on the α 2/β-adrenergic control of lipolysis in white fat cells: predominant α 2-antilipolytic response in testosterone-treated castrated hamsters. Endocrinology 122(6), 2590-2596 (1988).
66. Xu XF, De Pergola G, Bjorntorp P: Testosterone increases lipolysis and the number of β-adrenoceptors in male rat adipocytes. Endocrinology 128(1), 379-382 (1991).
67. Hernandez-Morante JJ, Perez-de-Heredia F, Lujan JA, Zamora S, Garaulet M: Role of DHEA-S on body fat distribution: gender-and depot-specific stimulation of adipose tissue lipolysis. Steroids 73(2), 209-215 (2008).
68. Dicker A, Ryden M, Naslund E et al.: Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia 47(3), 420-428 (2004).
69. Marin P, Lonn L, Andersson B et al.: Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J. Clin. Endocrinol. Metab. 81(3), 1018-1022 (1996).
70. Li M, Bjorntorp P: Effects of testosterone on triglyceride uptake and mobilization in different adipose tissues in male rats in vivo. Obes. Res. 3(2), 113-119 (1995).
71. Lanfranco F, Zitzmann M, Simoni M, Nieschlag E: Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy. Clin. Endocrinol. (Oxf.) 60(4), 500-507 (2004).
72. Page ST, Herbst KL, Amory JK et al.: Testosterone administration suppresses adiponectin levels in men. J. Androl. 26(1), 85-92 (2005).
73. Jockenhovel F, Blum WF, Vogel E et al.: Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. J. Clin. Endocrinol. Metab. 82(8), 2510-2513 (1997).
74. Machinal-Quelin F, Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y: Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine 18(2), 179-184 (2002).
75. Nishizawa H, Shimomura I, Kishida K et al.: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte derived protein. Diabetes 51(9), 2734-2741 (2002).
76. Horenburg S, Fischer-Posovszky P, Debatin KM, Wabitsch M: Influence of sex hormones on adiponectin expression in human adipocytes. Horm. Metab. Res. 40(11), 779-786 (2008).
77. Serazin-Leroy? V, Morot M, de Mazancourt P, Giudicelli Y: Androgen regulation and site specificity of angiotensinogen gene expression and secretion in rat adipocytes. Am. J. Physiol. Endocrinol. Metab. 279(6), E1398-E1405 (2000).
78. Malkin CJ, Pugh PJ, Jones RD et al.: The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J. Clin. Endocrinol. Metab. 89(7), 3313-3318 (2004).
79. Blouin K, Blanchette S, Richard C et al.: Expression and activity of steroid aldoketoreductases 1C in omental adipose tissue are positive correlates of adiposity in women. Am. J. Physiol. Endocrinol. Metab. 288(2), E398-E404 (2005).
80. Dufort I, Labrie F, Luu-The V: Human types 1 and 3 3 α-hydroxysteroid dehydrogenases: differential lability and tissue distribution. J. Clin. Endocrinol. Metab. 86(2), 841-846 (2001).
81. Zhang Y, Dufort I, Rheault P, Luu-The V: Characterization of a human 20α-hydroxy-steroid dehydrogenase. J. Mol. Endocrinol. 25(2), 221-228 (2000).
82. Blanchette S, Blouin K, Richard C et al.: Expression and activity of 20α-hydroxysteroid dehydrogenase (AKR1C1) in abdominal subcutaneous and omental adipose tissue in women. J. Clin. Endocrinol. Metab. 90(1), 264-270 (2005).
83. Wake DJ, Strand M, Rask E et al.: Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin. Endocrinol. (Oxf.) 66(3), 440-446 (2007).
84. Quinkler M, Sinha B, Tomlinson JW, Bujalska IJ, Stewart PM, Arlt W: Androgen generation in adipose tissue in women with simple obesity - a site-specific role for 17β-hydroxysteroid dehydrogenase type 5. J. Endocrinol. 183(2),331-342 (2004).
85. Walker BR, Andrew R: Tissue production of cortisol by 11β-hydroxysteroid dehydrogenase type 1 and metabolic disease. Ann. NY Acad. Sci. 1083, 165-184 (2006).
86. Lindsay RS, Wake DJ, Nair S et al.: Subcutaneous adipose 11 β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J. Clin. Endocrinol. Metab. 88(6), 2738-2744 (2003).
87. Paulsen SK, Pedersen SB, Fisker S, Richelsen B: 11B-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity 15(8), 1954-1960 (2007).
88. Kannisto K, Pietilainen KH, Ehrenborg E et al.: Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. J. Clin. Endocrinol. Metab. 89(9), 4414-4421 (2004).
89. Desbriere R, Vuaroqueaux V, Achard V et al.: 11β-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity 14(5), 794-798 (2006).
90. Michailidou Z, Jensen MD, Dumesic DA et al.: Omental 11β-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity 15(5), 1155-1163 (2007).
91. Veilleux A, Rhéaume M, Daris M, Tchernof A: Expression of glucocorticoid action-related genes in human subcutaneous and omental adipose tissue. J. Diabetes 1(1), A59 (2009).
92. Bujalska IJ, Kumar S, Hewison M, Stewart PM: Differentiation of adipose stromal cells: the roles of glucocorticoids and 11β-hydroxysteroid dehydrogenase. Endocrinology 140(7), 3188-3196 (1999).
93. Mackenzie SM, Huda SS, Sattar N, Fraser R, Connell JM, Davies E: Depot-specific steroidogenic gene transcription in human adipose tissue. Clin. Endocrinol. (Oxf.) 69(6), 848-854 (2008).
94. Jones ME, Thorburn AW, Britt KL et al.: Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc. Natl Acad. Sci. USA 97(23), 12735-12740 (2000).